Scienture Holdings, Inc. (SCNX) stock
SCNXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.76−0.23 (-7.69%)
Close on Nov 17, 2026Market cap $113.34MP/E –Yield –
Earnings
Scienture's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
–
Not yet scheduled
Revenue, Q2 FY2026
$343.64K
EPS, Q2 FY2026
-$0.07
Latest guidance
None
No outlook given in releases
Quarterly results
Revenue and earnings per share from each of Scienture's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | Aug 20, 2026after the close | $343.64K | – | -$0.07 | Release |
| Q1 FY2026ended Mar 31, 2026 | May 22, 2026after the close | $56.33K | – | -$0.08 | Release |
| Q1 FY2023ended Mar 31, 2023 | May 15, 2023after the close | $2.20M | -31.3% | – | Release |
| Q4 FY2022ended Dec 31, 2022 | Mar 27, 2023after the close | – | – | – | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 7, 2022after the close | $2.40M | -7.7% | -$0.06 | Release |
| Q2 FY2022ended Jun 30, 2022 | Jul 25, 2022after the close | $3.30M | – | -$0.13 | Release |
| Q1 FY2022ended Mar 31, 2022 | May 9, 2022after the close | $3.20M | – | -$0.12 | Release |
| Q4 FY2021ended Dec 31, 2021 | Mar 28, 2022after the close | $2.40M | – | -$0.10 | Release |
| Q3 FY2021ended Sep 30, 2021 | Oct 25, 2021after the close | $2.60M | – | -$0.16 | Release |
| Q2 FY2021ended Jun 30, 2021 | Jul 26, 2021after the close | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | Apr 26, 2021after the close | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Mar 29, 2021after the close | – | – | – | Filing |
| Q3 FY2020ended Sep 30, 2020 | Oct 26, 2020after the close | – | – | – | Filing |
| Q1 FY2020ended Mar 31, 2020 | May 4, 2020before the open | – | – | – | Filing |
| Q4 FY2019ended Dec 31, 2019 | Mar 30, 2020before the open | – | – | – | Filing |
| Q3 FY2019ended Sep 30, 2019 | Oct 31, 2019before the open | – | – | – | Filing |
| Q3 FY2015ended Sep 30, 2015 | Nov 2, 2015after the close | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
Scienture has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When Scienture puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases Scienture filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Update
- Update
- Results
- Results
- Update
- Update
- Update
- Update
- Update
- Update
- Update
- Update
- Update
- Update
See a number that looks wrong?